InvestorsHub Logo
Followers 10
Posts 1578
Boards Moderated 0
Alias Born 10/15/2014

Re: TRUISM post# 8692

Friday, 05/20/2016 5:39:52 PM

Friday, May 20, 2016 5:39:52 PM

Post# of 16911
Anyone notice the paragraph right before the one Truth quoted. It read...

"High profits in the middle of this epidemic are really unconscionable," she says.

Sheldon, of Braeburn Pharmaceuticals, says the company will offer rebates to make sure appropriate patients can get access to the implant. She plans to negotiate with insurers and providers on a price that takes both their cost and savings into account, she says.

"And if they don't realize those savings, we're happy to rebate them even further," Sheldon says.


So Braeburn plans to negotiate with insurers, pricing probuphine based on their potential savings...a return on investment argument. If they don't realize the savings, a sales credit/rebate? That speaks volumes. What other drug company basically guarantees that an insurer will realize cost savings?

Now that "Societal Outcomes" study (showing a 80% reduction in rehab, 97.0% reduction in accidental ingestion, etc.) makes sense.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TTNP News